ESR1 and breast cancer: Therefore, exposure to high-dose estrogen and progesterone through ART leads to an increase in ER and PR expression in breast cells, and it is possible that some still-unknown mechanism may cause this fraction of steroid receptor-positive cells to transition from a paracrine to an autocrine signaling mechanism, thereby inducing breast cancer development and progression.